September 16, 2025

State’s Largest HIV Outbreak Raises Alarms

Public health experts cite syringe shortages and encampment clearings as drivers of Penobscot County’s historic HIV outbreak.

KFF Health News

September 16, 2025

Fixing the Flaws in Opioid Disorder Care

How real-world data from millions of patients is helping uncover stark disparities in opioid use disorder treatment, and where targeted interventions could save lives.

Conexiant

September 15, 2025

The Hidden Hazard: Fall-Risk Drugs

US fall-related deaths in older adults are rising, with prescription drugs a key contributor and safer alternatives urged.

KFF Health News

September 15, 2025

1 in 5 US Med Students Food Insecure, Study

Loans, debt, and dependents drove food insecurity among US medical students.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 05, 2025

Extended-Release Risperidone Injection Receives FDA Approval

FDA approves Amneal’s risperidone extended-release injection for schizophrenia and Bipolar I maintenance.

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 02, 2025

New Maintenance Option for Early Alzheimer’s Approved by FDA

FDA approves Leqembi IQLIK (lecanemab-irmb), a once-weekly subcutaneous autoinjector for maintenance treatment of early Alzheimer’s disease.

Conexiant

August 27, 2025

Remission Patterns in Youth at Risk for Psychosis

When participants had at least 1 follow-up visit after achieving remission, the likelihood of staying in remission increased. 

Conexiant